These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19420977)

  • 1. Delayed oxaliplatin-induced sensorimotor polyneuropathy.
    Nardone R; Buratti T; Golaszewski S; Bratti A; Caleri F; Tezzon F; Ladurner G; Mitterer M
    Onkologie; 2009 May; 32(5):283-5. PubMed ID: 19420977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
    J Clin Oncol; 2009 Mar; 27(8):1243-9. PubMed ID: 19164207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.
    Krøigård T; Schrøder HD; Qvortrup C; Eckhoff L; Pfeiffer P; Gaist D; Sindrup SH
    Eur J Neurol; 2014 Apr; 21(4):623-9. PubMed ID: 24460946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin-induced neurotoxicity and the development of neuropathy.
    Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
    Muscle Nerve; 2005 Jul; 32(1):51-60. PubMed ID: 15880395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports.
    Bhagavati S; Maccabee P; Muntean E; Sumrani NB
    Transplant Proc; 2007 Dec; 39(10):3465-7. PubMed ID: 18089409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Oncology; 2009; 77(6):342-8. PubMed ID: 20016227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
    Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
    Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-associated neuropathy: a review.
    Cersosimo RJ
    Ann Pharmacother; 2005 Jan; 39(1):128-35. PubMed ID: 15590869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrodiagnostic pattern approach for childhood polyneuropathies.
    Polat M; Tekgul H; Kilincer A; Tosun A; Terlemez S; Serdaroglu G; Uludag B; Gokben S
    Pediatr Neurol; 2006 Jul; 35(1):11-7. PubMed ID: 16814079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Exp Neurol; 2011 Jan; 227(1):120-7. PubMed ID: 20965170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer.
    Chen X; Stubblefield MD; Custodio CM; Hudis CA; Seidman AD; DeAngelis LM
    J Clin Neurophysiol; 2013 Apr; 30(2):199-203. PubMed ID: 23545771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin and axonal Na+ channel function in vivo.
    Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
    Clin Cancer Res; 2006 Aug; 12(15):4481-4. PubMed ID: 16899592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib-associated demyelinating neuropathy--clinical and pathologic features.
    Thawani SP; Tanji K; De Sousa EA; Weimer LH; Brannagan TH
    J Clin Neuromuscul Dis; 2015 Jun; 16(4):202-9. PubMed ID: 25996966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.
    Zedan AH; Hansen TF; Fex Svenningsen A; Vilholm OJ
    Clin Colorectal Cancer; 2014 Jun; 13(2):73-80. PubMed ID: 24365057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of oxaliplatin-induced neuropathy.
    Burakgazi AZ; Messersmith W; Vaidya D; Hauer P; Hoke A; Polydefkis M
    Neurology; 2011 Sep; 77(10):980-6. PubMed ID: 21865571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and electromyographic deep tendon reflexes in polyneuropathy: diagnostic value and prevalence*.
    Sharma KR; Saadia D; Facca AG; Resnick S; Ayyar DR
    Acta Neurol Scand; 2009 Apr; 119(4):224-32. PubMed ID: 18664243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.